Bausch Health Companies Inc
BHC
Market Cap$2.55B
Close$
$12.03
70% upside
Current Fair Value
70% upsideUndervalued by 70% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.55 Billion |
|---|---|
| Enterprise Value | $23.89 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.24 |
| Beta | 1.41 |
| Outstanding Shares | 366,796,721 |
| Avg 30 Day Volume | 3,965,921 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.6 |
|---|---|
| PEG | 8.22 |
| Price to Sales | 0.3 |
| Price to Book Ratio | -1.77 |
| Enterprise Value to Revenue | 2.66 |
| Enterprise Value to EBIT | 14.28 |
| Enterprise Value to Net Income | -53 |
| Total Debt to Enterprise | 0.92 |
| Debt to Equity | -19.8 |
Revenue Sources
No data
ESG Score
No data
About Bausch Health Companies Inc
21,100 employeesBausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter ...